NCT05755269View on ClinicalTrials.gov

Adding a Genetic Risk Evaluation to Standard Breast Cancer Risk Assessment for African American and Hispanic Women

RecruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

March 14, 2023

Primary Completion Date

January 15, 2033

Study Completion Date

January 15, 2033

Conditions
Breast Atypical Ductal HyperplasiaBreast Atypical Lobular HyperplasiaBreast CarcinomaBreast Lobular Carcinoma In Situ
Interventions
PROCEDURE

Biospecimen Collection

Undergo collection of blood samples

PROCEDURE

Genotyping

Undergo genotyping

OTHER

Survey Administration

Complete surveys

Trial Locations (1)

32224-9980

RECRUITING

Mayo Clinic in Florida, Jacksonville

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT05755269 - Adding a Genetic Risk Evaluation to Standard Breast Cancer Risk Assessment for African American and Hispanic Women | Biotech Hunter | Biotech Hunter